Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in Aneurysmal Subarachnoid Hemorrhage
NCT01787123Phase 3Completed
- Sponsor
- Kwong Wah Hospital
- Start
- Dec 2013
- Primary completion
- Jan 2019
- Modality
- Native Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Cerebrolysin Arm with Placebo Arm (2 arms). Primary endpoint: Global functional performance at 6 months. Started Dec 2013; status: completed.
02
Drugs
cerebrolysin
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT01787123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787123.